U.S. Markets open in 16 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 32.83 10:18 AM EST | |
|---|---|---|
| Day High | 34.92 03:41 PM EST |
|
| Range | 2.09 |
| Volume | 33,204 | |
|---|---|---|
| 30-Day Avg Vol | 52,000 |
|
| Difference | -36.15% |
| Market Cap | 1.38 B | |
|---|---|---|
| Mkt Cap Chg | 51.35 M |
| Shares Out | 40.11 M | |
|---|---|---|
| % Shrs Traded | 0.08% | |
| 1yr EPS Est | -1.89 |
| 52-Wk Low | 24.52 | |
|---|---|---|
| 52-Wk High | 74.50 |
|
| Range | 49.98 |
| Prev Close | 33.15 11/5/09 | |
|---|---|---|
| Today's Open | 33.65 | |
| Change | 1.51% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 397,810.00 |
| Revenue (LFY) | 345.30 M | |
|---|---|---|
| Earnings (LFY) | -276.77 M | |
| Earnings (MRQ) | -23.43 M | |
| Next Earn Est | -0.49 | |
| Next Earnings | 03/01/2010 |
|
| EPS (TTM) | -6.07 | |
| 1yr EPS Growth | 71.75% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -18.00 | |
| PEG Ratio | — | |
| Return on Equity | -26.01 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cancer patients will hopefully get a helpful shot in the arm thanks to Abraxis BioScience. The company's oncology and research division is developing a line of injectable drugs starting with Abraxane, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.49 3/1/10 | — — |
—
—
|
| Last Quarter | -0.55 9/30/09 | -0.94 9/30/09 |
-0.39
Missed
|
| 2 Quarters Ago | — 6/30/09 | -0.58 6/30/09 |
—
—
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 85.13 M | 345.31 M |
| Gross Profit | 60.56 M | 266.81 M |
| Operating Income | -26.07 M | -53.58 M |
| Net Income | -23.43 M | -276.77 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts